Ergoteles’s CTS Corp CTS Stock Holding History

Ergoteles’s Portfolio CTS Stock Details CTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,437	Closed	-$609K	–	1353
2022 Q4	$609K	Buy	15,437 +9,737	+171%	+$401K	0.02%	629
2022 Q3	$237K	Buy	+5,700	New	+$229K	0.01%	1096

Other funds holding CTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ergoteles's CTS Position: Q1 2023 in Review

Ergoteles sold out of CTS Corp (CTS) in Q1 2023, closing a stake of 15,437 shares — an estimated $609K sold.

Ergoteles first reported a position in CTS in Q3 2022 and held it in 2 quarters. The position peaked at $609K in Q4 2022. 201 funds tracked by Wall St. Rank hold CTS as of Q1 2023.

Ergoteles reported no remaining CTS Corp position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 15,437 CTS Corp shares in Q1 2023, an estimated $609K.
Ergoteles first reported a position in CTS Corp in Q3 2022 and held it in 2 quarters.
Ergoteles's CTS Corp position peaked at $609K in Q4 2022.
201 funds tracked by Wall St. Rank held CTS Corp as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.